Corrigendum to "Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update"
- PMID: 31379947
- PMCID: PMC6662276
- DOI: 10.1155/2019/4120631
Corrigendum to "Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update"
Abstract
[This corrects the article DOI: 10.1155/2014/986938.].
Erratum for
-
Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.Adv Hematol. 2014;2014:986938. doi: 10.1155/2014/986938. Epub 2014 Nov 27. Adv Hematol. 2014. PMID: 25525436 Free PMC article. Review.
References
-
- Freifeld A. G., Bow E. J., Sepkowitz K. A., et al. Executive summary: clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2011;52(4):427–431. doi: 10.1093/cid/ciq147. - DOI - PubMed
-
- Gea-Banacloche J. Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2013;2013:414–422. - PubMed
-
- Safdar A. Principles and Practice of Cancer Infectious Diseases. 2011. - DOI
Publication types
LinkOut - more resources
Full Text Sources